A new vaccine cuts children's chances of contracting malaria in half, according to a major clinical trial sub-Saharan Africa. It is the first successful malaria vaccine and could be an indispensable tool in the fight to eradicate the disease.
An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease.
U.S. health officials are looking to capitalize on significant gains in flu vaccination rates with a new campaign emphasizing the need for all Americans over six months of age to get a flu shot.
The issue of the longevity gene has now created a feud between two trans-Atlantic camps of researchers. While the British scientists claim the days of longevity gene are over, the US scientists still have faith in the success of the gene.
A gene scientists say delivers the fountain of youth may just a bucket of water, according to research published today.
Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.
South Africa's Aspen Pharmacare could spend some $800 million on acquisitions, its deputy CEO said, as Africa's biggest generic drugs maker looks for further targets, particularly in Latin America.
For the second year in a row, health experts are urging all Americans to get a flu shot, even though the circulating strains of flu have not changed since the 2010-2011 flu season.
Scientists say their discovery of "super antibody" FI6, which can fight all types of influenza A viruses that cause disease in humans and animals, may serve as a turning point in the development of new flu treatments.
Scientists have found a flu "super antibody" called FI6 that can fight all types of influenza A viruses that cause disease in humans and animals and say their discovery may be a turning point in the development of new flu treatments.
A group of major western pharmaceutical companies announced that they will significantly reduce the prices they charge for vaccines in the developing world.
The companies whose shares are moving in pre-market trade on Wednesday are: Corning, Baker Hughes, Carnival Corp, Boeing, Hess Corp, Merck & Co, GlaxoSmithKline, LDK Solar, FMC Technologies, Rockwell Automation and Johnson & Johnson.
XenoPort (NASDAQ: XNPT) and GlaxoSmithKline Plc (LON: GSK) said the U.S. Food and Drug Administration (FDA) has approved Horizant, a treatment for restless legs syndrome (RLS) that the companies developed together.
The top pre-market NASDAQ Stock Market gainers are: Xenoport, ZAGG, Bed Bath & Beyond, Immucor, Immunogen, and China Gerui Advanced Materials Group. The top pre-market NASDAQ Stock Market losers are: Qiao Xing Universal Resources, Travelzoo, Power-One, Advanced Energy Industries, and ASML Holding.
The top after-market NASDAQ Stock Market gainers are: Xenoport, Bed Bath & Beyond, Immucor, Fortinet, and Tesco. The top after-market NASDAQ Stock Market losers are: Power-One, Tuesday Morning, Advanced Analogic Technologies, ISTA Pharmaceuticals, and Lincare Holdings.
The top pre-market NASDAQ stock market gainers are: Green Mountain Coffee Roasters, Human Genome Sciences, Semtech, Starbucks and Atrinsic. The top pre-market NASDAQ stock market losers are: Coldwater Creek, Peet's Coffee & Tea, Canadian Solar, ARM Holdings, and SIGA Technologies.
The top after-market NASDAQ stock market gainers are: Netease.com, ArQule, Biogen Idec, priceline.com, and Leap Wireless International. The top after-market NASDAQ stock market losers are: AXT, InterDigital, POZEN, Calumet Specialty Products Partners, and United Online.
The Bill and Melinda Gates Foundation is helping partners in China improve child vaccines, roll out faster TB detection kits and make higher-yielding rice which it hopes can be used later in other parts of the world.
The top pre-market NASDAQ stock market gainers are: Sequenom, Whole Foods Market, Progenics Pharmaceuticals, Clearwire, and Xenoport. The top pre-market NASDAQ stock market losers are: Idenix Pharmaceuticals, EZchip Semiconductor, Amkor Technology, TriQuint Semiconductor, Akamai Technologies, and Cisco Systems.
The top after-market NASDAQ stock market gainers are: Select Comfort, Whole Foods Market, 1-800-Flowers.com, SuccessFactors, and LeCroy. The top after-market NASDAQ stock market losers are: Idenix Pharmaceuticals, Pacer International, TriQuint Semiconductor, Amkor Technology, and Akamai Technologies.
Pharma major GlaxoSmithKline Plc posted a quarterly loss hit by a massive charge to settle further litigation related to its diabetes drug Avandia, but the company raised its dividend and said it would resume its share buyback program.
The top pre-market NASDAQ stock market losers are: LTX-Credence, BroadSoft, Cninsure, YRC Worldwide, Human Genome Sciences, Celgene, Identive Group, Randgold Resources, Qiagen, and Corinthian Colleges.
